San Diego, CA, United States of America

Robert Martin Demoret

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Martin Demoret

Introduction

Robert Martin Demoret is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for pain treatment. His work is characterized by a focus on innovative solutions that address complex medical challenges.

Latest Patents

Demoret holds a patent for "Heteroaryl compounds for the treatment of pain." This patent includes compounds and pharmaceutically acceptable salts that serve as inhibitors of sodium channels. The patent also outlines pharmaceutical compositions that incorporate these compounds and methods for their use in treating various disorders, including pain.

Career Highlights

Demoret is currently associated with Vertex Pharmaceuticals, Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Vertex has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Demoret has worked alongside Dennis James Hurley, a fellow innovator in the field. Their collaboration has likely fostered advancements in their shared research interests, particularly in the area of pain management.

Conclusion

Robert Martin Demoret's contributions to pharmaceutical innovations, particularly in pain treatment, highlight his role as a significant inventor in the industry. His patent and work at Vertex Pharmaceuticals, Inc. underscore the importance of innovation in addressing medical needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…